+44 7474964491
[email protected]
Contact Us

Blogs

Stay informed with the latest trends, updates, and expert insights in quality assurance, regulatory affairs, and compliance. Our blogs are designed to keep you ahead in the ever-evolving world of healthcare and pharmaceuticals.

Subscribe Now
EU GVP Module III Revision 2 Explained: What Changed and Who It Affects
15 Oct
GVP Audits

EU GVP Module III Revision 2 Explained: What Changed and Who It Affects

Pharmacovigilance for PLPI Holders: What the MHRA Expects from a Parallel Import Licensee
13 Oct
Pharmacovigilance Services

Pharmacovigilance for PLPI Holders: What the MHRA Expects from a Parallel Import Licensee

Pharmacovigilance Services for Generic Drug Companies: What’s Different 
08 Oct
Uncategorized

Pharmacovigilance Services for Generic Drug Companies: What’s Different 

Due Diligence Audits for Pharma M&A: Quality and PV Risk Assessment Services
06 Oct
Pharmacovigilance Services

Due Diligence Audits for Pharma M&A: Quality and PV Risk Assessment Services

Remote GMP Audits: How Virtual Inspections Work and What’s Different 
01 Oct
Pharma Audits

Remote GMP Audits: How Virtual Inspections Work and What’s Different 

Deviation and CAPA System Design Services for Growing Pharma Companies 
29 Sep
Risk-Based Audits

Deviation and CAPA System Design Services for Growing Pharma Companies 

Compliance Support for Pharma Startups Launching Their First Product in the UK
24 Sep
Pharmacovigilance Services

Compliance Support for Pharma Startups Launching Their First Product in the UK

Received an FDA 483 Observation? How to Find Emergency Remediation Support 
22 Sep
Pharmacovigilance Services

Received an FDA 483 Observation? How to Find Emergency Remediation Support 

India PvPI Reporting Obligations: What MAH Audit Readiness Looks Like
17 Sep
Pharmacovigilance Services

India PvPI Reporting Obligations: What MAH Audit Readiness Looks Like

WHO Prequalification for Indian Manufacturers: Where Sites Commonly Fail
15 Sep
Pharma Audits

WHO Prequalification for Indian Manufacturers: Where Sites Commonly Fail

FDA Pre-Approval Inspection Readiness: What Inspectors Test First
10 Sep
Pharma Audits

FDA Pre-Approval Inspection Readiness: What Inspectors Test First

FDA Drug Shortage Reporting Under Section 506C: When and What to File
08 Sep
Pharma Audits

FDA Drug Shortage Reporting Under Section 506C: When and What to File

UK Controlled Drug Licence for Wholesalers: Schedule 2 to 5 Obligations
03 Sep
Risk-Based Audits

UK Controlled Drug Licence for Wholesalers: Schedule 2 to 5 Obligations

WDA(H) Licence Application: Why the MHRA Rejects More Than You Think
01 Sep
Pharma Audits

WDA(H) Licence Application: Why the MHRA Rejects More Than You Think

Why Some Companies Fail Inspections on Training Records, Not Case Quality
27 Aug
Pharma Audits

Why Some Companies Fail Inspections on Training Records, Not Case Quality

What Auditors Actually Check in Your Case Processing Workflow
25 Aug
Pharmacovigilance Services

What Auditors Actually Check in Your Case Processing Workflow

Why Smaller Pharma Companies Get Hit Harder by GMP Findings Than They 
20 Aug
Pharma Audits

Why Smaller Pharma Companies Get Hit Harder by GMP Findings Than They 

Temperature Excursions in GDP: What to Do in the First 24 Hours
18 Aug
Pharmacovigilance Services

Temperature Excursions in GDP: What to Do in the First 24 Hours

The Hidden Cost of Not Having a UK Responsible Person
13 Aug
Pharmacovigilance Services

The Hidden Cost of Not Having a UK Responsible Person

What Happens After You Receive a Critical MHRA Finding
11 Aug
Pharma Audits

What Happens After You Receive a Critical MHRA Finding

MHRA Inspection Findings: Top 15 Deficiencies Reported in 2025-2026 
06 Aug
Pharmacovigilance Services

MHRA Inspection Findings: Top 15 Deficiencies Reported in 2025-2026 

Annex 1 Sterile Manufacturing: Frequently Missed Compliance Requirements
04 Aug
Pharma Audits

Annex 1 Sterile Manufacturing: Frequently Missed Compliance Requirements

CSV vs CSA: Which Validation Approach Should UK Pharma Companies Follow?
30 Jul
GVP Audits

CSV vs CSA: Which Validation Approach Should UK Pharma Companies Follow?

GMP Consultant vs Full-Time Quality Manager: Which Is Better for SMEs?
28 Jul
Pharma Audits

GMP Consultant vs Full-Time Quality Manager: Which Is Better for SMEs?

ALCOA++ Checklist for Pharmaceutical Manufacturers
23 Jul
Pharmacovigilance Services

ALCOA++ Checklist for Pharmaceutical Manufacturers

How to Prepare a Vendor Qualification File That Passes Regulatory Review
21 Jul
Risk-Based Audits

How to Prepare a Vendor Qualification File That Passes Regulatory Review

Your CMO Has a GMP Certificate. Here’s Why That’s Not Enough for Your Next MHRA Inspection 
16 Jul
Pharma Audits

Your CMO Has a GMP Certificate. Here’s Why That’s Not Enough for Your Next MHRA Inspection 

Generic Drug Companies and Signal Detection: Why You Can’t Copy Your Originator’s PV System
14 Jul
Risk-Based Audits

Generic Drug Companies and Signal Detection: Why You Can’t Copy Your Originator’s PV System

The Hidden Cost of Repeat Inspection Findings – and How to Break the Cycle 
09 Jul
Risk-Based Audits

The Hidden Cost of Repeat Inspection Findings – and How to Break the Cycle 

Five Indian Pharma Companies Got FDA Warning Letters in Q1 2026 for the Same Mistake: Here’s the Pattern 
07 Jul
Pharmacovigilance Services

Five Indian Pharma Companies Got FDA Warning Letters in Q1 2026 for the Same Mistake: Here’s the Pattern 

Import Alert 66-40 Explained: How One Data Integrity Finding Can Block Your Entire Supply Chain for 18 Months
02 Jul
Risk-Based Audits

Import Alert 66-40 Explained: How One Data Integrity Finding Can Block Your Entire Supply Chain for 18 Months

The FDA Just Issued Its First Warning Letter for AI Misuse in CGMP Documentation: Here’s What Happened
30 Jun
Risk-Based Audits

The FDA Just Issued Its First Warning Letter for AI Misuse in CGMP Documentation: Here’s What Happened

GDP Compliance for Cold Chain Logistics: Updated Requirements and Audit Checklist
25 Jun
GVP Audits

GDP Compliance for Cold Chain Logistics: Updated Requirements and Audit Checklist

The New EU Pharmaceutical Legislation 2026: What Changes for Pharmacovigilance?
23 Jun
Pharmacovigilance Services

The New EU Pharmaceutical Legislation 2026: What Changes for Pharmacovigilance?

FDA Draft Guidance on Responding to Form 483 Observations: A Practical Guide for CGMP Sites
18 Jun
Pharma Audits

FDA Draft Guidance on Responding to Form 483 Observations: A Practical Guide for CGMP Sites

FDA’s New Overseas Inspection Approach: What Pharma Sites Need to Know
16 Jun
Pharmacovigilance Services

FDA’s New Overseas Inspection Approach: What Pharma Sites Need to Know

EMA and FDA Issue Joint Principles on AI in Medicine Development: What It Means for PV Teams
11 Jun
Pharmacovigilance Services

EMA and FDA Issue Joint Principles on AI in Medicine Development: What It Means for PV Teams

GDP 2026: Understanding MHRA, DSCSA, and Global Traceability Requirements
09 Jun
Pharma Audits

GDP 2026: Understanding MHRA, DSCSA, and Global Traceability Requirements

Root Cause Analysis Tools for GxP CAPA: When to Use Ishikawa, 5-Why and Fault Tree Analysis 
04 Jun
GVP Audits Pharmacovigilance Services

Root Cause Analysis Tools for GxP CAPA: When to Use Ishikawa, 5-Why and Fault Tree Analysis 

PSMF Maintenance Checklist: What Needs Updating After a Licence Variation, Product Transfer or MAH Change
02 Jun
Pharma Audits

PSMF Maintenance Checklist: What Needs Updating After a Licence Variation, Product Transfer or MAH Change

CE Mark vs National Device Approvals: How Global Medical Device Manufacturers Should Plan Their Compliance Strategy in 2026
28 May
Pharmacovigilance Services

CE Mark vs National Device Approvals: How Global Medical Device Manufacturers Should Plan Their Compliance Strategy in 2026

EMA, FDA and MHRA GMP Annex Revisions 2026- 2028: What Every Pharma QA Team Must Prepare For
26 May
Pharma Audits

EMA, FDA and MHRA GMP Annex Revisions 2026- 2028: What Every Pharma QA Team Must Prepare For

GMP Mock Inspection for Pharmaceutical Manufacturers: What Global Regulators Check That Internal Teams Miss
21 May
Pharma Audits

GMP Mock Inspection for Pharmaceutical Manufacturers: What Global Regulators Check That Internal Teams Miss

How to Respond to a Regulatory Deficiency Letter: A Step-by-Step CAPA Guide for Pharmaceutical Sites
19 May
GVP Audits Pharma Audits

How to Respond to a Regulatory Deficiency Letter: A Step-by-Step CAPA Guide for Pharmaceutical Sites

EU QPPV Services: Cost Comparison In-House vs Outsourced QPPV for MAHs in 2026
14 May
Pharmacovigilance Services

EU QPPV Services: Cost Comparison In-House vs Outsourced QPPV for MAHs in 2026

End-to-End GxP Quality and Pharmacovigilance Services: Integrated vs Fragmented PV
12 May
Pharmacovigilance Services

End-to-End GxP Quality and Pharmacovigilance Services: Integrated vs Fragmented PV

Drug Safety Consulting for Social Media ADR Reporting: NLP and Data Mining Strategies
07 May
Pharmacovigilance Services

Drug Safety Consulting for Social Media ADR Reporting: NLP and Data Mining Strategies

GxP Quality Services: FDA’s 112 Warning Letters and System Misalignment Findings
05 May
Risk-Based Audits

GxP Quality Services: FDA’s 112 Warning Letters and System Misalignment Findings

Pharmacovigilance Audit Services: Verifying Social Media Listening Programs for Regulatory Compliance
30 Apr
Pharmacovigilance Services

Pharmacovigilance Audit Services: Verifying Social Media Listening Programs for Regulatory Compliance

DARWIN EU Real-World Evidence: How Drug Safety Consulting Services Use 250 Million Patient Records
28 Apr
Pharma Audits

DARWIN EU Real-World Evidence: How Drug Safety Consulting Services Use 250 Million Patient Records

Before Your QA Meeting: 10 Quality Signals Every Leader Should Track
23 Apr
Pharma Audits Risk-Based Audits

Before Your QA Meeting: 10 Quality Signals Every Leader Should Track

Let’s build a GxP-compliant future together.

Have a project in mind?

Partner with us to elevate your quality systems, ensure compliance, and drive meaningful business transformation.

Contact Us Now

Built with passion and purpose. Helping you grow smarter, not harder.

QUICK LINKS

CONTACT US

+44 7474964491
[email protected]

Newsletter Signup

Subscribe to our newsletter for the latest insights

Copyright © 2026 Quality Vigilance Ltd | All Rights Reserved || Powered by Prabisha Consulting

Newsletter Signup

Subscribe to our newsletter for the latest insights